ALMR
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. (ALMR) has 3 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Apr 20, 2026.
Insiders have net bought $4.0M over the trailing 6 months. The largest single insider purchase in this window was $4.0M by Insider Naclerio Nicholas on Apr 20, 2026.
- Industry:Biotechnology
- CEO:Justin J. McAnear
- Employees:222
- HQ:Fremont, CA, US
- IPO:2026-04-17
Insider Buying
$4.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Naclerio NicholasFirst filing | Insider | Purchase | 235,294 | $4.0M | Apr 20 | SEC ↗ |
Related companies
Alamar Biosciences, Inc. is in the Healthcare sector.